Providing integrated drug discovery services to pharma, biotechnology companies and academic institutions. Read more
- About Selcia
- News & Events
- Contact Us
An initiative is under way to develop new drugs for a devastating tropical disease that threatens almost 70 million people in Africa.
Selcia Limited, the international life sciences CRO, has announced a successful inspection of its GMP radiochemistry facility by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA).
Selcia Limited, the international life sciences CRO, has appointed John Davis to the newly created role of Director of Discovery.